ROTIGOTINE

ROTIGOTINE was reported 14738 times

ROTIGOTINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DOPAMINE AGONIST WITHDRAWAL SYNDROME 12 0.2222
1 PARKINSONIAN CRISIS 20 0.1942
2 NEUROPROSTHESIS IMPLANTATION 20 0.1439
3 RESTLESS LEG AUGMENTATION SYNDROME 20 0.1290
4 STOMA SITE EXTRAVASATION 36 0.0933
5 STOMA SITE INDURATION 11 0.0924
6 STOMA SITE ODOUR 20 0.0893
7 PARKINSONISM HYPERPYREXIA SYNDROME 15 0.0838
8 DROPPED HEAD SYNDROME 33 0.0835
9 ANTIDIURETIC HORMONE ABNORMALITY 7 0.0833
10 STOMA SITE HYPERGRANULATION 50 0.0792
11 ON AND OFF PHENOMENON 428 0.0770
12 STOMA SITE INFLAMMATION 51 0.0683
13 DOPAMINE DYSREGULATION SYNDROME 29 0.0650
14 REDUCED FACIAL EXPRESSION 64 0.0631
15 DEEP BRAIN STIMULATION 38 0.0629
16 STOMA SITE ERYTHEMA 115 0.0615
17 STOMA SITE REACTION 41 0.0599
18 FREEZING PHENOMENON 217 0.0586
19 STOMA SITE DISCHARGE 156 0.0569
20 STOMA SITE PAIN 83 0.0565
21 PRODUCT ADHESION ISSUE 1963 0.0549
22 SLEEP ATTACKS 26 0.0546
23 HYPERKINESIA 95 0.0448
24 CATHETER SITE INDURATION 8 0.0415
25 STOMA SITE INFECTION 52 0.0399
26 STOMA SITE DISCOMFORT 9 0.0396
27 AKINESIA 76 0.0367
28 STOMA SITE OEDEMA 8 0.0365
29 CATHETER SITE BRUISE 12 0.0363
30 IMPULSE-CONTROL DISORDER 74 0.0359
31 STOMA SITE IRRITATION 19 0.0349
32 CAMPTOCORMIA 8 0.0333
33 SALIVA DISCOLOURATION 11 0.0329
34 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 13 0.0323
35 APPLICATION SITE REACTION 222 0.0315
36 COMPULSIONS 21 0.0315
37 APPLICATION SITE HYPERSENSITIVITY 38 0.0313
38 BRADYKINESIA 184 0.0311
39 PARKINSONIAN GAIT 19 0.0304
40 SEXUALLY INAPPROPRIATE BEHAVIOUR 14 0.0300
41 ORTHOSTATIC INTOLERANCE 21 0.0292
42 INFUSION SITE INDURATION 43 0.0290
43 STOMA SITE ABSCESS 7 0.0288
44 FIBROMA 24 0.0261
45 STOMA SITE HAEMORRHAGE 40 0.0260
46 SUDDEN ONSET OF SLEEP 36 0.0259
47 SLEEP TALKING 43 0.0253
48 HYPERSEXUALITY 45 0.0246
49 DEVICE ADHESION ISSUE 377 0.0245
50 ENTERAL NUTRITION 14 0.0241
51 PARKINSON'S DISEASE 61 0.0240
52 PRODUCT INEFFECTIVE 18 0.0229
53 MUSCLE RIGIDITY 274 0.0229
54 INFUSION SITE CELLULITIS 12 0.0227
55 DEVICE COLOUR ISSUE 9 0.0223
56 DEVICE LOOSENING 19 0.0220
57 INFUSION SITE ABSCESS 11 0.0218
58 APPLICATION SITE DERMATITIS 20 0.0214
59 COMPULSIVE SHOPPING 43 0.0209
60 MULTIPLE SYSTEM ATROPHY 7 0.0199
61 APPLICATION SITE PRURITUS 446 0.0196
62 OROMANDIBULAR DYSTONIA 14 0.0192
63 INFUSION SITE HAEMATOMA 9 0.0189
64 RESTLESS LEGS SYNDROME 343 0.0188
65 STEREOTYPY 17 0.0180
66 POSTURE ABNORMAL 57 0.0175
67 DYSKINESIA 698 0.0172
68 APPLICATION SITE ERYTHEMA 446 0.0170
69 STARVATION 13 0.0156
70 INFUSION SITE INFLAMMATION 11 0.0156
71 THERAPEUTIC PRODUCT EFFECT VARIABLE 60 0.0154
72 APPLICATION SITE RASH 202 0.0147
73 MULTIPLE DRUG THERAPY 11 0.0146
74 INFUSION SITE NODULE 14 0.0146
75 GAMBLING DISORDER 39 0.0144
76 APPLICATION SITE VESICLES 91 0.0140
77 DEVICE CONNECTION ISSUE 29 0.0137
78 SALIVA ALTERED 12 0.0133
79 CAMPYLOBACTER INFECTION 11 0.0132
80 BEZOAR 18 0.0130
81 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 13 0.0129
82 APPLICATION SITE URTICARIA 29 0.0129
83 DRUG DOSE TITRATION NOT PERFORMED 23 0.0125
84 DYSLALIA 9 0.0124
85 DRUG EFFECT VARIABLE 13 0.0115
86 PATHOLOGICAL GAMBLING 19 0.0114
87 GAMBLING 13 0.0111
88 INFUSION SITE MASS 12 0.0110
89 DEVICE ALARM ISSUE 20 0.0110
90 APPLICATION SITE SWELLING 52 0.0104
91 HALLUCINATION, VISUAL 219 0.0104
92 DELUSION 161 0.0104
93 HALLUCINATION 771 0.0102
94 BINGE EATING 11 0.0102
95 DEVICE KINK 37 0.0101
96 SUSPICIOUSNESS 7 0.0100
97 EXCESSIVE GRANULATION TISSUE 8 0.0099
98 STOMA COMPLICATION 10 0.0098
99 APPLICATION SITE IRRITATION 120 0.0096
100 PERSECUTORY DELUSION 24 0.0096
101 RECALL PHENOMENON 8 0.0096
102 MUCOSAL HAEMORRHAGE 11 0.0095
103 REHABILITATION THERAPY 35 0.0090
104 DEFAECATION DISORDER 6 0.0090
105 LIBIDO INCREASED 18 0.0089
106 FEAR OF FALLING 7 0.0086
107 NOCTURIA 104 0.0086
108 DEVICE OCCLUSION 119 0.0084
109 COVID-19 IMMUNISATION 7 0.0084
110 BLADDER CATHETERISATION 8 0.0083
111 PRODUCT DISPENSING ISSUE 35 0.0082
112 APPLICATION SITE DISCOLOURATION 33 0.0081
113 SPUTUM RETENTION 8 0.0081
114 INFREQUENT BOWEL MOVEMENTS 20 0.0080
115 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 6 0.0078
116 DAYDREAMING 12 0.0078
117 THERAPEUTIC PRODUCT INEFFECTIVE 30 0.0078
118 YAWNING 20 0.0075
119 STERNAL FRACTURE 9 0.0073
120 FINE MOTOR SKILL DYSFUNCTION 21 0.0072
121 APPLICATION SITE BRUISE 7 0.0072
122 APPLICATION SITE SCAR 9 0.0072
123 DEMENTIA WITH LEWY BODIES 8 0.0072
124 DYSTONIA 139 0.0072
125 GASTROSTOMY 11 0.0071
126 SLEEP DEFICIT 15 0.0071
127 HYPOKINESIA 101 0.0070
128 GALLBLADDER CANCER 10 0.0068
129 NOSOCOMIAL INFECTION 15 0.0068
130 DROOLING 47 0.0068
131 TERMINAL INSOMNIA 12 0.0068
132 GASTROINTESTINAL MOTILITY DISORDER 36 0.0067
133 WEIGHT ABNORMAL 16 0.0067
134 ILLUSION 11 0.0066
135 INITIAL INSOMNIA 68 0.0066
136 FLUID INTAKE REDUCED 33 0.0066
137 PRODUCT AVAILABILITY ISSUE 149 0.0065
138 MEDICAL DEVICE PAIN 14 0.0065
139 PALLIATIVE CARE 10 0.0065
140 INFUSION SITE WARMTH 8 0.0065
141 LIVING IN RESIDENTIAL INSTITUTION 12 0.0064
142 PARKINSONISM 62 0.0064
143 DECUBITUS ULCER 51 0.0063
144 PNEUMONIA ASPIRATION 156 0.0062
145 DYSCHEZIA 19 0.0062
146 SLOW RESPONSE TO STIMULI 8 0.0062
147 DERMATITIS CONTACT 69 0.0060
148 INFUSION SITE REACTION 18 0.0060
149 PNEUMOPERITONEUM 11 0.0059
150 IMMOBILE 26 0.0059
151 MICTURITION URGENCY 68 0.0059
152 DECREASED INTEREST 35 0.0059
153 DROWNING 6 0.0059
154 PRODUCT RESIDUE PRESENT 32 0.0059
155 PROSTATIC OPERATION 7 0.0058
156 NASAL DISCHARGE DISCOLOURATION 8 0.0058
157 APPLICATION SITE INFLAMMATION 8 0.0058
158 TENSION 35 0.0057
159 WALKING DISABILITY 12 0.0057
160 HIP SURGERY 31 0.0057
161 INFUSION SITE BRUISING 12 0.0056
162 APPLICATION SITE WARMTH 7 0.0055
163 APPLICATION SITE BURN 26 0.0053
164 THERAPEUTIC PRODUCT EFFECT DELAYED 24 0.0053
165 CONTRAINDICATION TO MEDICAL TREATMENT 8 0.0052
166 TORTICOLLIS 11 0.0052
167 DILATATION ATRIAL 6 0.0051
168 DISCOURAGEMENT 12 0.0051
169 INFUSION SITE DISCHARGE 9 0.0051
170 FEMORAL NECK FRACTURE 26 0.0051
171 VOLVULUS 12 0.0051
172 DEMENTIA 141 0.0050
173 CHOKING 97 0.0050
174 DISINHIBITION 8 0.0050
175 PHARMACEUTICAL PRODUCT COMPLAINT 129 0.0050
176 TRACHEOSTOMY 7 0.0049
177 OBSESSIVE-COMPULSIVE DISORDER 39 0.0049
178 POLYCYTHAEMIA 10 0.0048
179 MIDDLE INSOMNIA 90 0.0048
180 POOR QUALITY SLEEP 103 0.0048
181 SLEEP PARALYSIS 7 0.0048
182 NARCOLEPSY 9 0.0048
183 INFECTED SKIN ULCER 9 0.0048
184 HALLUCINATIONS, MIXED 20 0.0048
185 WHEELCHAIR USER 21 0.0047
186 MOTOR DYSFUNCTION 48 0.0047
187 NEUROLEPTIC MALIGNANT SYNDROME 55 0.0046
188 INFUSION SITE ERYTHEMA 38 0.0045
189 BEDRIDDEN 59 0.0045
190 CYSTITIS NONINFECTIVE 6 0.0045
191 INABILITY TO AFFORD MEDICATION 44 0.0044
192 INHIBITORY DRUG INTERACTION 7 0.0044
193 SALIVARY HYPERSECRETION 44 0.0044
194 MOVEMENT DISORDER 141 0.0044
195 INFARCTION 30 0.0044
196 FAECES HARD 17 0.0044
197 ANOSMIA 63 0.0043
198 IMPULSIVE BEHAVIOUR 16 0.0043
199 CATHETER SITE ERYTHEMA 9 0.0042
200 ABNORMAL DREAMS 115 0.0042
201 THERAPEUTIC RESPONSE SHORTENED 135 0.0041
202 MEDICAL DEVICE REMOVAL 7 0.0040
203 DIPLEGIA 8 0.0040
204 GASTROINTESTINAL TUBE INSERTION 10 0.0040
205 TREMOR 655 0.0039
206 MEDICAL DEVICE DISCOMFORT 12 0.0039
207 DELIRIUM 136 0.0039
208 CLAVICLE FRACTURE 15 0.0039
209 ORTHOSTATIC HYPOTENSION 68 0.0039
210 SPINAL OPERATION 48 0.0039
211 DRUG TITRATION ERROR 10 0.0039
212 INFUSION SITE INFECTION 9 0.0039
213 PANIC DISORDER 15 0.0039
214 SPEECH DISORDER 200 0.0038
215 THERMAL BURN 27 0.0038
216 MOBILITY DECREASED 273 0.0038
217 APPLICATION SITE PAIN 82 0.0037
218 SNORING 14 0.0037
219 ABDOMINAL RIGIDITY 10 0.0037
220 INGUINAL HERNIA 22 0.0036
221 ANAL INCONTINENCE 32 0.0036
222 RESTLESSNESS 129 0.0035
223 PSYCHIATRIC SYMPTOM 26 0.0035
224 CERVICAL VERTEBRAL FRACTURE 12 0.0035
225 BLOOD CHLORIDE INCREASED 6 0.0035
226 CATHETER SITE PAIN 9 0.0035
227 AUTONOMIC NERVOUS SYSTEM IMBALANCE 10 0.0034
228 COMMUNICATION DISORDER 13 0.0034
229 NIGHTMARE 117 0.0034
230 ASPIRATION 37 0.0034
231 PARALYSIS 48 0.0033
232 WALKING AID USER 22 0.0033
233 SLOW SPEECH 8 0.0033
234 FAECALOMA 18 0.0033
235 NONSPECIFIC REACTION 18 0.0033
236 SEXUAL DYSFUNCTION 38 0.0032
237 THERAPY INTERRUPTED 231 0.0032
238 BALANCE DISORDER 278 0.0032
239 ELECTRIC SHOCK SENSATION 9 0.0032
240 HIP FRACTURE 103 0.0032
241 SOMNAMBULISM 21 0.0032
242 DYSPHAGIA 303 0.0032
243 SPINAL STENOSIS 13 0.0031
244 HALLUCINATION, AUDITORY 50 0.0031
245 BEHAVIOUR DISORDER 17 0.0031
246 DEVICE DISLOCATION 136 0.0031
247 HYPERVENTILATION 18 0.0031
248 CHRONIC GASTRITIS 7 0.0031
249 DEVICE POWER SOURCE ISSUE 9 0.0031
250 PSYCHOMOTOR HYPERACTIVITY 51 0.0031
251 DEVICE PLACEMENT ISSUE 11 0.0031
252 BRAIN OPERATION 7 0.0031
253 DENGUE FEVER 7 0.0030
254 FALL 1013 0.0030
255 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 214 0.0030
256 HOSPICE CARE 29 0.0029
257 GAIT INABILITY 98 0.0029
258 COGNITIVE DISORDER 136 0.0029
259 HYPOPHAGIA 73 0.0029
260 LOGORRHOEA 10 0.0028
261 INCONTINENCE 30 0.0028
262 FACIAL PARESIS 10 0.0028
263 OXYGEN SATURATION ABNORMAL 8 0.0028
264 ABNORMAL FAECES 23 0.0028
265 CATHETER SITE HAEMORRHAGE 7 0.0028
266 INCOHERENT 18 0.0028
267 APPLICATION SITE SCAB 6 0.0028
268 PSYCHOTIC DISORDER 82 0.0028
269 LIVER ABSCESS 9 0.0028
270 SKIN REACTION 39 0.0028
271 PHYSICAL DECONDITIONING 7 0.0027
272 DEVICE ISSUE 242 0.0027
273 PRODUCT PACKAGING DIFFICULT TO OPEN 7 0.0027
274 PRODUCT ADMINISTRATION INTERRUPTED 21 0.0027
275 PSYCHOMOTOR SKILLS IMPAIRED 7 0.0027
276 MUSCULOSKELETAL STIFFNESS 233 0.0027
277 PRODUCT CLEANING INADEQUATE 7 0.0026
278 DERMATITIS ALLERGIC 33 0.0026
279 BRADYPHRENIA 17 0.0026
280 SHOULDER ARTHROPLASTY 7 0.0026
281 APHASIA 78 0.0026
282 RIB FRACTURE 53 0.0026
283 ASPHYXIA 21 0.0026
284 ALTERED STATE OF CONSCIOUSNESS 55 0.0025
285 DISORIENTATION 100 0.0025
286 RESPIRATORY ARREST 69 0.0025
287 EPILEPSY 75 0.0025
288 DYSARTHRIA 92 0.0024
289 DEPRESSED MOOD 129 0.0024
290 GAIT DISTURBANCE 466 0.0024
291 VITAMIN B12 DECREASED 7 0.0024
292 LISTLESS 8 0.0024
293 EMBEDDED DEVICE 24 0.0024
294 PRE-EXISTING CONDITION IMPROVED 15 0.0024
295 DYSSTASIA 70 0.0024
296 INFUSION SITE SWELLING 15 0.0024
297 PRODUCT PHYSICAL ISSUE 48 0.0024
298 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 114 0.0024
299 PHOTOPSIA 15 0.0024
300 SOMNOLENCE 477 0.0024
301 INFUSION SITE PAIN 30 0.0023
302 SKIN ABRASION 11 0.0023
303 FEEDING DISORDER 47 0.0023
304 MICTURITION DISORDER 8 0.0023
305 DYSAESTHESIA 7 0.0023
306 ABNORMAL BEHAVIOUR 90 0.0023
307 SKIN MASS 15 0.0022
308 SENSORY DISTURBANCE 36 0.0022
309 TERMINAL STATE 15 0.0022
310 FOREIGN BODY IN THROAT 7 0.0022
311 UNEVALUABLE EVENT 168 0.0022
312 DEVICE PHYSICAL PROPERTY ISSUE 17 0.0022
313 UPPER LIMB FRACTURE 44 0.0022
314 PARANOIA 38 0.0022
315 CLUMSINESS 6 0.0022
316 HYPERSOMNIA 63 0.0022
317 APPLICATION SITE HAEMORRHAGE 6 0.0022
318 APPLICATION SITE EXFOLIATION 9 0.0022
319 DEVICE USE ISSUE 38 0.0022
320 GENERAL PHYSICAL HEALTH DETERIORATION 251 0.0022
321 HYPERTENSIVE CRISIS 24 0.0022
322 DIPLOPIA 56 0.0022
323 SLEEP DISORDER 152 0.0022
324 FEELING OF DESPAIR 10 0.0021
325 VARICOSE VEIN 11 0.0021
326 CARDIO-RESPIRATORY ARREST 89 0.0021
327 HEAD INJURY 67 0.0021
328 CATHETER SITE INFECTION 8 0.0021
329 ACCIDENT 25 0.0021
330 INTENTIONAL PRODUCT MISUSE 183 0.0021
331 BOWEL MOVEMENT IRREGULARITY 16 0.0021
332 WRIST FRACTURE 25 0.0021
333 SPINAL COMPRESSION FRACTURE 17 0.0021
334 DYSPHEMIA 9 0.0021
335 PRODUCT DISTRIBUTION ISSUE 19 0.0020
336 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 35 0.0020
337 BLOOD PRESSURE FLUCTUATION 49 0.0020
338 SCREAMING 13 0.0020
339 FEMUR FRACTURE 63 0.0020
340 SKIN IRRITATION 93 0.0020
341 CONFUSIONAL STATE 327 0.0020
342 AGGRESSION 101 0.0020
343 PRESCRIBED OVERDOSE 39 0.0020
344 AGITATION 148 0.0020
345 SLEEP APNOEA SYNDROME 38 0.0020
346 ERYSIPELAS 10 0.0020
347 DEPRESSIVE SYMPTOM 7 0.0020
348 CRANIOCEREBRAL INJURY 6 0.0020
349 GALLBLADDER OPERATION 8 0.0020
350 OVERDOSE 426 0.0020
351 DISEASE COMPLICATION 9 0.0020
352 PERIPHERAL VENOUS DISEASE 8 0.0020
353 FRACTURE 37 0.0020
354 EYE OPERATION 9 0.0020
355 COVID-19 PNEUMONIA 23 0.0019
356 KNEE OPERATION 19 0.0019
357 ILEUS 24 0.0019
358 MALABSORPTION 10 0.0019
359 ELECTROENCEPHALOGRAM ABNORMAL 6 0.0019
360 INSURANCE ISSUE 29 0.0019
361 HUMERUS FRACTURE 9 0.0019
362 TEARFULNESS 8 0.0019
363 PROTEIN TOTAL DECREASED 7 0.0019
364 CATARACT OPERATION 11 0.0019
365 FACE INJURY 7 0.0018
366 SKIN LACERATION 20 0.0018
367 POLYNEUROPATHY 22 0.0018
368 DISTURBANCE IN ATTENTION 99 0.0018
369 OESOPHAGEAL ULCER 7 0.0018
370 INFLAMMATORY MARKER INCREASED 9 0.0018
371 URINARY TRACT INFECTION 309 0.0018
372 LOSS OF CONSCIOUSNESS 232 0.0018
373 ABDOMINAL ABSCESS 8 0.0018
374 FOOT DEFORMITY 20 0.0018
375 MEMORY IMPAIRMENT 247 0.0018
376 INTENTIONAL UNDERDOSE 13 0.0018
377 SLUGGISHNESS 18 0.0018
378 SECRETION DISCHARGE 22 0.0018
379 HYPERPHAGIA 7 0.0018
380 INSOMNIA 466 0.0017
381 UNRESPONSIVE TO STIMULI 45 0.0017
382 THERAPEUTIC PRODUCT EFFECT DECREASED 78 0.0017
383 AGEUSIA 43 0.0017
384 URINARY INCONTINENCE 51 0.0017
385 LIGAMENT SPRAIN 17 0.0017
386 PANIC ATTACK 62 0.0017
387 DUODENAL ULCER 12 0.0017
388 HAND FRACTURE 12 0.0017
389 DYSGRAPHIA 11 0.0017
390 PELVIC FRACTURE 13 0.0017
391 CORONAVIRUS INFECTION 11 0.0017
392 EUPHORIC MOOD 17 0.0017
393 COMPLICATION ASSOCIATED WITH DEVICE 24 0.0017
394 EATING DISORDER 35 0.0016
395 HIP ARTHROPLASTY 25 0.0016
396 EXPIRED DRUG ADMINISTERED 8 0.0016
397 LIMB DISCOMFORT 50 0.0016
398 SENSORY LOSS 13 0.0016
399 SKIN SWELLING 14 0.0016
400 JOINT DISLOCATION 17 0.0016
401 MUSCLE TWITCHING 37 0.0016
402 SPINAL OSTEOARTHRITIS 14 0.0016
403 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 29 0.0016
404 PRODUCT PACKAGING ISSUE 15 0.0016
405 DECREASED ACTIVITY 17 0.0016
406 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 319 0.0016
407 CEREBRAL ISCHAEMIA 8 0.0016
408 URINARY TRACT DISORDER 7 0.0016
409 PRESCRIBED UNDERDOSE 31 0.0016
410 PRODUCT PRESCRIBING ERROR 37 0.0016
411 HYPERHIDROSIS 199 0.0015
412 TRANSIENT ISCHAEMIC ATTACK 52 0.0015
413 LUMBAR VERTEBRAL FRACTURE 7 0.0015
414 ARTHRITIS INFECTIVE 7 0.0015
415 PERSONALITY CHANGE 14 0.0015
416 COORDINATION ABNORMAL 21 0.0015
417 COMPRESSION FRACTURE 8 0.0015
418 DEPRESSED LEVEL OF CONSCIOUSNESS 59 0.0015
419 SYNCOPE 149 0.0015
420 LACERATION 14 0.0015
421 UNINTENTIONAL MEDICAL DEVICE REMOVAL 17 0.0015
422 HEAD DISCOMFORT 26 0.0015
423 HICCUPS 12 0.0015
424 IMPAIRED QUALITY OF LIFE 21 0.0015
425 SUBCUTANEOUS ABSCESS 7 0.0015
426 LIMB OPERATION 7 0.0015
427 INTESTINAL ISCHAEMIA 8 0.0015
428 SCOLIOSIS 9 0.0015
429 FOOT OPERATION 7 0.0014
430 DIABETIC NEUROPATHY 7 0.0014
431 METASTASIS 10 0.0014
432 PERITONITIS 29 0.0014
433 THINKING ABNORMAL 26 0.0014
434 PANIC REACTION 10 0.0014
435 MUSCLE SPASTICITY 17 0.0014
436 CONSTIPATION 301 0.0014
437 APPETITE DISORDER 9 0.0014
438 POST PROCEDURAL COMPLICATION 26 0.0014
439 RESPIRATORY RATE INCREASED 12 0.0014
440 ARTHROPOD BITE 10 0.0013
441 ANXIETY 379 0.0013
442 FOOD CRAVING 7 0.0013
443 GASTRITIS 35 0.0013
444 GENERAL PHYSICAL CONDITION ABNORMAL 9 0.0013
445 ERECTILE DYSFUNCTION 34 0.0013
446 MYOCARDIAL ISCHAEMIA 15 0.0013
447 MUSCULOSKELETAL DISORDER 25 0.0013
448 BLADDER DISORDER 13 0.0013
449 APATHY 19 0.0013
450 CIRCULATORY COLLAPSE 22 0.0013
451 PNEUMONIA 415 0.0013
452 CHOKING SENSATION 7 0.0013
453 SPUTUM DISCOLOURED 12 0.0013
454 FEAR 34 0.0013
455 MENTAL DISORDER 55 0.0013
456 ACUTE MYOCARDIAL INFARCTION 37 0.0013
457 MALNUTRITION 14 0.0013
458 HOSPITALISATION 192 0.0012
459 NERVOUSNESS 65 0.0012
460 GENERALISED ERYTHEMA 7 0.0012
461 SUDDEN DEATH 13 0.0012
462 SURGERY 72 0.0012
463 ADVERSE REACTION 16 0.0012
464 URINARY RETENTION 40 0.0012
465 SPINAL FRACTURE 24 0.0012
466 SEROTONIN SYNDROME 23 0.0012
467 MENTAL IMPAIRMENT 29 0.0012
468 ACUTE RESPIRATORY FAILURE 23 0.0012
469 PULMONARY THROMBOSIS 13 0.0012
470 DYSPHORIA 6 0.0012
471 TROPONIN INCREASED 9 0.0012
472 DEVICE BREAKAGE 48 0.0012
473 JOINT INJURY 25 0.0012
474 PRODUCT DOSE OMISSION ISSUE 343 0.0012
475 CONCUSSION 9 0.0012
476 MUSCULAR WEAKNESS 132 0.0012
477 THERAPEUTIC RESPONSE UNEXPECTED 52 0.0012
478 RESPIRATORY TRACT INFECTION 30 0.0012
479 DRY MOUTH 93 0.0011
480 DYSPHONIA 67 0.0011
481 AFFECTIVE DISORDER 9 0.0011
482 GLAUCOMA 22 0.0011
483 DEATH 984 0.0011
484 DEFAECATION URGENCY 8 0.0011
485 KNEE ARTHROPLASTY 24 0.0011
486 PALLOR 31 0.0011
487 GROIN PAIN 10 0.0011
488 PRODUCT ADMINISTRATION ERROR 23 0.0011
489 GRIP STRENGTH DECREASED 10 0.0011
490 WEIGHT DECREASED 317 0.0011
491 DIZZINESS POSTURAL 11 0.0011
492 PRODUCT QUALITY ISSUE 154 0.0011
493 SCIATICA 18 0.0011
494 SEIZURE 130 0.0011
495 MUSCLE SPASMS 206 0.0011
496 KIDNEY INFECTION 22 0.0011
497 ARRHYTHMIA 53 0.0011
498 FRUSTRATION TOLERANCE DECREASED 9 0.0011
499 BRUXISM 6 0.0011
500 VISUAL FIELD DEFECT 8 0.0011
501 TONGUE DISORDER 8 0.0011
502 PRODUCT PRESCRIBING ISSUE 24 0.0011
503 UROSEPSIS 10 0.0011
504 IRON DEFICIENCY ANAEMIA 10 0.0011
505 HEMIPLEGIA 9 0.0011
506 CEREBRAL DISORDER 8 0.0011
507 TREATMENT NONCOMPLIANCE 59 0.0011
508 FEELING DRUNK 8 0.0011
509 WOUND 30 0.0011
510 ANGIOPATHY 6 0.0011
511 FEELING ABNORMAL 256 0.0011
512 CYSTITIS 34 0.0011
513 GENERAL SYMPTOM 8 0.0011
514 CEREBRAL INFARCTION 26 0.0011
515 INTESTINAL OBSTRUCTION 40 0.0011
516 PAROSMIA 8 0.0011
517 CONDITION AGGRAVATED 322 0.0011
518 BLOOD PRESSURE ABNORMAL 21 0.0011
519 UNDERDOSE 77 0.0011
520 OFF LABEL USE 922 0.0011
521 CARDIAC VALVE DISEASE 6 0.0010
522 DIZZINESS 523 0.0010
523 HYPERTHERMIA 8 0.0010
524 WITHDRAWAL SYNDROME 44 0.0010
525 AMNESIA 68 0.0010
526 MYOPATHY 9 0.0010
527 LOWER LIMB FRACTURE 20 0.0010
528 DRUG EFFECT DECREASED 56 0.0010
529 HYSTERECTOMY 9 0.0010
530 DEVICE LEAKAGE 45 0.0010
531 POSTOPERATIVE WOUND INFECTION 7 0.0010
532 IMPAIRED GASTRIC EMPTYING 14 0.0010
533 CYANOSIS 16 0.0010
534 ENERGY INCREASED 6 0.0010
535 ABASIA 25 0.0010
536 CARDIAC FAILURE 81 0.0010
537 CARDIAC PACEMAKER INSERTION 6 0.0010
538 HIATUS HERNIA 13 0.0010
539 GASTRIC ULCER 19 0.0010
540 DEPRESSION 227 0.0010
541 BLISTER 56 0.0010
542 DRUG INTERACTION 158 0.0010
543 DRUG EFFECT INCOMPLETE 36 0.0010
544 MOOD ALTERED 27 0.0010
545 HAEMATEMESIS 25 0.0010
546 SUBARACHNOID HAEMORRHAGE 10 0.0010
547 ASTHENIA 369 0.0010
548 SKIN INFECTION 11 0.0010
549 ROAD TRAFFIC ACCIDENT 41 0.0010
550 BRAIN NEOPLASM 9 0.0010
551 SUBDURAL HAEMATOMA 14 0.0010
552 ANGER 33 0.0010
553 MITRAL VALVE INCOMPETENCE 11 0.0010
554 INTERNAL HAEMORRHAGE 11 0.0010
555 CATARACT 57 0.0010
556 ISCHAEMIC STROKE 17 0.0010
557 PRODUCT USE COMPLAINT 15 0.0010
558 BLOOD PRESSURE DECREASED 63 0.0009
559 MUSCLE ATROPHY 12 0.0009
560 PERIPHERAL COLDNESS 13 0.0009
561 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 44 0.0009
562 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
563 NEPHROLITHIASIS 43 0.0009
564 CARDIAC ARREST 77 0.0009
565 IRRITABILITY 56 0.0009
566 SKIN CANCER 20 0.0009
567 MUSCLE STRAIN 8 0.0009
568 INCORRECT DOSE ADMINISTERED BY DEVICE 24 0.0009
569 INTERVERTEBRAL DISC PROTRUSION 20 0.0009
570 INTENTIONAL DOSE OMISSION 26 0.0009
571 PRODUCT COMMUNICATION ISSUE 8 0.0009
572 LYMPHOCYTE COUNT DECREASED 16 0.0009
573 ADVERSE DRUG REACTION 81 0.0009
574 CARDIAC FAILURE ACUTE 6 0.0009
575 HYPOTENSION 180 0.0009
576 SEPSIS 100 0.0009
577 SUICIDAL IDEATION 82 0.0009
578 RETCHING 19 0.0009
579 INCREASED APPETITE 17 0.0009
580 DRUG INEFFECTIVE 1171 0.0009
581 WRONG TECHNIQUE IN DRUG USAGE PROCESS 32 0.0009
582 ABNORMAL LOSS OF WEIGHT 6 0.0009
583 ULCER 14 0.0009
584 IMPAIRED DRIVING ABILITY 10 0.0009
585 NEUTROPHIL COUNT INCREASED 9 0.0009
586 SEDATION 23 0.0009
587 DRUG EFFECT LESS THAN EXPECTED 13 0.0009
588 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 9 0.0009
589 DEVICE DIFFICULT TO USE 58 0.0009
590 INCORRECT DOSE ADMINISTERED 200 0.0009
591 CONTUSION 84 0.0009
592 PNEUMONIA BACTERIAL 8 0.0009
593 MUSCLE DISORDER 7 0.0009
594 MUSCLE TIGHTNESS 14 0.0009
595 PERIPHERAL SWELLING 132 0.0009
596 OEDEMA PERIPHERAL 104 0.0009
597 VERTIGO 52 0.0009
598 CRYING 31 0.0009
599 LIMB INJURY 23 0.0008
600 FLUID RETENTION 43 0.0008
601 SPINAL DISORDER 8 0.0008
602 FEELING JITTERY 16 0.0008
603 RESPIRATORY DISTRESS 23 0.0008
604 SOPOR 11 0.0008
605 BRAIN FOG 13 0.0008
606 DERMATITIS BULLOUS 6 0.0008
607 MALAISE 363 0.0008
608 PRESYNCOPE 20 0.0008
609 WOUND INFECTION 9 0.0008
610 ATRIAL FIBRILLATION 80 0.0008
611 MALIGNANT MELANOMA 11 0.0008
612 EMOTIONAL DISORDER 25 0.0008
613 HAEMATOMA 21 0.0008
614 STEVENS-JOHNSON SYNDROME 18 0.0008
615 TOOTH EXTRACTION 10 0.0008
616 HYPOTONIA 8 0.0008
617 RASH MACULAR 28 0.0008
618 PRODUCT USE ISSUE 150 0.0008
619 RESPIRATORY FAILURE 58 0.0008
620 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 7 0.0008
621 SUICIDE ATTEMPT 48 0.0008
622 FOOT FRACTURE 15 0.0008
623 HYPOTHERMIA 8 0.0008
624 AORTIC ANEURYSM 6 0.0008
625 CARDIOVASCULAR DISORDER 20 0.0008
626 DISCOMFORT 48 0.0008
627 CARPAL TUNNEL SYNDROME 11 0.0008
628 DEVICE RELATED INFECTION 12 0.0008
629 HERNIA 15 0.0008
630 ANKLE FRACTURE 12 0.0008
631 DIALYSIS 11 0.0008
632 ENCEPHALOPATHY 19 0.0008
633 ERYTHEMA 159 0.0008
634 MELAENA 17 0.0008
635 RASH GENERALISED 20 0.0008
636 APNOEA 6 0.0008
637 SPINAL PAIN 9 0.0008
638 DEHYDRATION 102 0.0008
639 WEIGHT FLUCTUATION 8 0.0008
640 DECREASED APPETITE 176 0.0008
641 BLOOD ALBUMIN DECREASED 6 0.0008
642 CHOLECYSTITIS 9 0.0008
643 CHROMATURIA 17 0.0008
644 BLOOD DISORDER 6 0.0007
645 DEVICE USE ERROR 26 0.0007
646 JOINT RANGE OF MOTION DECREASED 10 0.0007
647 ARTERIOSCLEROSIS 7 0.0007
648 RHABDOMYOLYSIS 31 0.0007
649 C-REACTIVE PROTEIN INCREASED 27 0.0007
650 NEURALGIA 18 0.0007
651 THERAPY CESSATION 38 0.0007
652 VOMITING 348 0.0007
653 BACK DISORDER 12 0.0007
654 BLOOD PRESSURE INCREASED 112 0.0007
655 CARDIOMEGALY 9 0.0007
656 BLOOD CREATINE PHOSPHOKINASE INCREASED 21 0.0007
657 MANIA 12 0.0007
658 SKIN LESION 20 0.0007
659 GENERALISED OEDEMA 9 0.0007
660 MYOCARDIAL INFARCTION 126 0.0007
661 PRODUCT DOSE OMISSION 47 0.0007
662 POLLAKIURIA 30 0.0007
663 STATUS EPILEPTICUS 8 0.0007
664 RENAL DISORDER 33 0.0007
665 DISABILITY 14 0.0007
666 NAUSEA 555 0.0007
667 ROTATOR CUFF SYNDROME 9 0.0007
668 INFLAMMATION 36 0.0007
669 BLOOD MAGNESIUM DECREASED 6 0.0007
670 OXYGEN SATURATION DECREASED 39 0.0007
671 PARAESTHESIA 108 0.0007
672 INTENTIONAL OVERDOSE 44 0.0007
673 DRUG ADMINISTRATION ERROR 21 0.0007
674 COLD SWEAT 12 0.0007
675 HYPERTENSION 144 0.0007
676 LETHARGY 39 0.0007
677 HYPONATRAEMIA 38 0.0007
678 BLOOD IRON DECREASED 8 0.0007
679 MACULAR DEGENERATION 8 0.0007
680 TRANSFUSION 7 0.0007
681 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
682 OSTEOARTHRITIS 28 0.0007
683 SKIN ULCER 17 0.0007
684 CORONARY ARTERY OCCLUSION 9 0.0007
685 HAEMATOCRIT DECREASED 13 0.0007
686 CEREBROVASCULAR ACCIDENT 111 0.0007
687 HEART RATE DECREASED 23 0.0007
688 FEELING HOT 40 0.0007
689 PERICARDIAL EFFUSION 15 0.0006
690 THYROID DISORDER 10 0.0006
691 PAIN IN EXTREMITY 191 0.0006
692 CYST 8 0.0006
693 HEPATIC STEATOSIS 12 0.0006
694 COVID-19 113 0.0006
695 HEPATIC FUNCTION ABNORMAL 24 0.0006
696 CEREBRAL HAEMORRHAGE 23 0.0006
697 PLEURAL EFFUSION 39 0.0006
698 NERVOUS SYSTEM DISORDER 20 0.0006
699 WEIGHT INCREASED 143 0.0006
700 BLOOD SODIUM DECREASED 12 0.0006
701 DRUG INTOLERANCE 61 0.0006
702 VENTRICULAR FIBRILLATION 7 0.0006
703 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
704 CONTRAINDICATED PRODUCT ADMINISTERED 19 0.0006
705 ABSCESS 10 0.0006
706 DRUG PRESCRIBING ERROR 12 0.0006
707 INTESTINAL PERFORATION 7 0.0006
708 LOCALISED INFECTION 15 0.0006
709 HEART RATE INCREASED 61 0.0006
710 JOINT STIFFNESS 16 0.0006
711 CHOLELITHIASIS 20 0.0006
712 SKIN DISCOLOURATION 28 0.0006
713 MULTIPLE FRACTURES 10 0.0006
714 NECK PAIN 34 0.0006
715 GASTRIC HAEMORRHAGE 7 0.0006
716 SARS-COV-2 TEST POSITIVE 8 0.0006
717 VISUAL IMPAIRMENT 75 0.0006
718 EXTRAPYRAMIDAL DISORDER 15 0.0006
719 COLON CANCER 9 0.0006
720 ELECTROLYTE IMBALANCE 7 0.0006
721 FATIGUE 469 0.0006
722 EXPIRED PRODUCT ADMINISTERED 20 0.0006
723 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 33 0.0006
724 SKIN DISORDER 20 0.0006
725 DYSURIA 22 0.0006
726 MOOD SWINGS 19 0.0006
727 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 107 0.0006
728 PRODUCT COMPLAINT 15 0.0006
729 TACHYPNOEA 8 0.0006
730 COMA 28 0.0006
731 MYOCLONUS 7 0.0006
732 HYPOACUSIS 25 0.0006
733 BLOOD URINE PRESENT 11 0.0006
734 TOOTH LOSS 12 0.0006
735 CELLULITIS 29 0.0006
736 HEART RATE IRREGULAR 13 0.0006
737 ABDOMINAL DISTENSION 60 0.0006
738 TACHYCARDIA 51 0.0006
739 DERMATITIS 12 0.0006
740 THROMBOSIS 46 0.0006
741 HYPERKALAEMIA 20 0.0006
742 SMALL INTESTINAL OBSTRUCTION 7 0.0006
743 VISION BLURRED 78 0.0006
744 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
745 HYPOXIA 20 0.0006
746 PNEUMOTHORAX 9 0.0006
747 ILL-DEFINED DISORDER 34 0.0006
748 INFECTION 81 0.0006
749 PRURITUS 215 0.0006
750 OSTEOPOROSIS 23 0.0006
751 JAUNDICE 15 0.0006
752 POISONING 7 0.0006
753 HYPOGLYCAEMIA 27 0.0006
754 ANAEMIA 106 0.0006
755 PRURITUS GENERALISED 12 0.0006
756 PARAESTHESIA ORAL 8 0.0006
757 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
758 BIPOLAR DISORDER 6 0.0006
759 BACK INJURY 6 0.0006
760 LOWER RESPIRATORY TRACT INFECTION 25 0.0005
761 GASTROENTERITIS 8 0.0005
762 EYE DISORDER 18 0.0005
763 BACK PAIN 127 0.0005
764 STAPHYLOCOCCAL INFECTION 18 0.0005
765 PRODUCTIVE COUGH 26 0.0005
766 ILLNESS 56 0.0005
767 ANOREXIA 7 0.0005
768 COUGH 152 0.0005
769 LIP SWELLING 18 0.0005
770 MENTAL STATUS CHANGES 15 0.0005
771 INJECTION SITE INDURATION 7 0.0005
772 TOOTH DISORDER 12 0.0005
773 FEELING COLD 15 0.0005
774 DIABETES MELLITUS 41 0.0005
775 PYREXIA 186 0.0005
776 IMMUNODEFICIENCY 8 0.0005
777 ORAL PAIN 12 0.0005
778 CARDIAC DISORDER 50 0.0005
779 THERAPY NON-RESPONDER 24 0.0005
780 BLOOD POTASSIUM DECREASED 16 0.0005
781 ORAL CANDIDIASIS 7 0.0005
782 HYPOCALCAEMIA 10 0.0005
783 HYPOAESTHESIA 79 0.0005
784 DRUG DISPENSING ERROR 8 0.0005
785 DEVICE DEFECTIVE 9 0.0005
786 PANCYTOPENIA 29 0.0005
787 EXTRA DOSE ADMINISTERED 21 0.0005
788 EJECTION FRACTION DECREASED 8 0.0005
789 PULMONARY OEDEMA 23 0.0005
790 BRONCHITIS 38 0.0005
791 BASAL CELL CARCINOMA 8 0.0005
792 PAIN 310 0.0005
793 ANAPHYLACTIC SHOCK 13 0.0005
794 PALPITATIONS 59 0.0005
795 MEDICATION ERROR 28 0.0005
796 DYSPNOEA 285 0.0005
797 GASTROINTESTINAL DISORDER 45 0.0005
798 ADVERSE EVENT 46 0.0005
799 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 26 0.0005
800 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
801 INTENTIONAL SELF-INJURY 10 0.0005
802 BURSITIS 6 0.0005
803 NASAL CONGESTION 29 0.0005
804 SINUS TACHYCARDIA 7 0.0005
805 HYPERSENSITIVITY 91 0.0005
806 PULMONARY EMBOLISM 46 0.0005
807 ARTHRITIS 38 0.0005
808 RENAL FAILURE 64 0.0005
809 RASH ERYTHEMATOUS 23 0.0005
810 NEOPLASM MALIGNANT 32 0.0005
811 DRUG WITHDRAWAL SYNDROME 42 0.0005
812 ABDOMINAL PAIN LOWER 12 0.0005
813 HEMIPARESIS 8 0.0005
814 DEVICE MALFUNCTION 33 0.0005
815 CHOLESTASIS 9 0.0005
816 PROCEDURAL PAIN 13 0.0005
817 ABDOMINAL PAIN 109 0.0005
818 THROAT IRRITATION 21 0.0005
819 SCAR 8 0.0005
820 MUSCULOSKELETAL DISCOMFORT 8 0.0005
821 RHINORRHOEA 30 0.0005
822 NEUROPATHY PERIPHERAL 44 0.0005
823 PRODUCT DISPENSING ERROR 10 0.0005
824 LOCAL SWELLING 8 0.0005
825 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
826 IMPAIRED HEALING 15 0.0005
827 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
828 LYMPHOMA 7 0.0005
829 MUSCULOSKELETAL CHEST PAIN 7 0.0005
830 TENDONITIS 7 0.0005
831 RASH 197 0.0005
832 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
833 LEUKOCYTOSIS 8 0.0004
834 OSTEOMYELITIS 8 0.0004
835 HAEMATOCHEZIA 24 0.0004
836 RESPIRATORY DISORDER 13 0.0004
837 NIGHT SWEATS 14 0.0004
838 HEADACHE 271 0.0004
839 BLOOD POTASSIUM INCREASED 7 0.0004
840 APHONIA 6 0.0004
841 CORONARY ARTERY DISEASE 13 0.0004
842 LUNG DISORDER 21 0.0004
843 INJURY 30 0.0004
844 OEDEMA 23 0.0004
845 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
846 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 30 0.0004
847 CHEST PAIN 78 0.0004
848 CHEST DISCOMFORT 43 0.0004
849 ANGINA PECTORIS 12 0.0004
850 BLOOD UREA INCREASED 7 0.0004
851 BRADYCARDIA 22 0.0004
852 ACCIDENTAL OVERDOSE 15 0.0004
853 GASTROOESOPHAGEAL REFLUX DISEASE 33 0.0004
854 GASTRIC DISORDER 14 0.0004
855 ABDOMINAL PAIN UPPER 83 0.0004
856 HERPES ZOSTER 23 0.0004
857 NEUROTOXICITY 7 0.0004
858 THERAPEUTIC RESPONSE DECREASED 24 0.0004
859 ABDOMINAL DISCOMFORT 66 0.0004
860 GOUT 7 0.0004
861 INFLUENZA 43 0.0004
862 BURNING SENSATION 27 0.0004
863 SWOLLEN TONGUE 12 0.0004
864 HYPERGLYCAEMIA 14 0.0004
865 DRUG-INDUCED LIVER INJURY 12 0.0004
866 DEAFNESS 10 0.0004
867 HAEMOGLOBIN DECREASED 39 0.0004
868 MYALGIA 64 0.0004
869 DYSPEPSIA 37 0.0004
870 CHILLS 44 0.0004
871 BACTERIAL INFECTION 7 0.0004
872 SWELLING 35 0.0004
873 BLADDER CANCER 22 0.0004
874 CARDIAC FAILURE CONGESTIVE 30 0.0004
875 ACUTE KIDNEY INJURY 56 0.0004
876 LUNG NEOPLASM MALIGNANT 15 0.0004
877 JOINT SWELLING 44 0.0004
878 DRUG LEVEL INCREASED 6 0.0004
879 DIVERTICULITIS 10 0.0004
880 CANDIDA INFECTION 6 0.0004
881 GASTRIC CANCER 9 0.0004
882 INTENTIONAL PRODUCT USE ISSUE 31 0.0004
883 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
884 FLATULENCE 20 0.0004
885 RASH PRURITIC 19 0.0004
886 COMPLETED SUICIDE 29 0.0003
887 GASTROINTESTINAL HAEMORRHAGE 29 0.0003
888 HYPOKALAEMIA 16 0.0003
889 PANCREATIC CARCINOMA 10 0.0003
890 RENAL IMPAIRMENT 29 0.0003
891 TASTE DISORDER 7 0.0003
892 BODY TEMPERATURE INCREASED 7 0.0003
893 URTICARIA 57 0.0003
894 DEEP VEIN THROMBOSIS 22 0.0003
895 INTENTIONAL DRUG MISUSE 7 0.0003
896 MULTIPLE SCLEROSIS 16 0.0003
897 FREQUENT BOWEL MOVEMENTS 9 0.0003
898 FIBROMYALGIA 8 0.0003
899 TINNITUS 15 0.0003
900 BLOOD GLUCOSE ABNORMAL 6 0.0003
901 FAECES DISCOLOURED 7 0.0003
902 INCORRECT DRUG ADMINISTRATION DURATION 9 0.0003
903 TARDIVE DYSKINESIA 9 0.0003
904 ARTHRALGIA 132 0.0003
905 COLITIS 12 0.0003
906 ANGIOEDEMA 14 0.0003
907 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
908 LIVER DISORDER 14 0.0003
909 HAEMORRHAGE 33 0.0003
910 DRUG DOSE OMISSION 52 0.0003
911 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
912 ARTHROPATHY 17 0.0003
913 SHOCK 7 0.0003
914 DYSGEUSIA 22 0.0003
915 DEVICE DELIVERY SYSTEM ISSUE 8 0.0003
916 HAEMATURIA 10 0.0003
917 NASOPHARYNGITIS 53 0.0003
918 MIGRAINE 27 0.0003
919 RENAL FAILURE ACUTE 12 0.0003
920 PRODUCT USE IN UNAPPROVED INDICATION 68 0.0003
921 DRUG RESISTANCE 7 0.0003
922 LABORATORY TEST ABNORMAL 8 0.0003
923 DIARRHOEA 174 0.0003
924 LACRIMATION INCREASED 8 0.0003
925 BLOOD CREATININE INCREASED 17 0.0003
926 PAIN OF SKIN 7 0.0003
927 PNEUMONITIS 7 0.0003
928 RECTAL HAEMORRHAGE 11 0.0003
929 SEPTIC SHOCK 11 0.0003
930 DRUG ABUSE 21 0.0003
931 DISEASE RECURRENCE 12 0.0003
932 SKIN BURNING SENSATION 18 0.0003
933 HYPOTHYROIDISM 8 0.0003
934 MUSCULOSKELETAL PAIN 13 0.0002
935 DRY EYE 12 0.0002
936 VIRAL INFECTION 8 0.0002
937 FUNGAL INFECTION 8 0.0002
938 PRODUCT STORAGE ERROR 21 0.0002
939 HOT FLUSH 18 0.0002
940 NO ADVERSE EVENT 43 0.0002
941 CHRONIC KIDNEY DISEASE 18 0.0002
942 PROSTATE CANCER 19 0.0002
943 BLOOD CHOLESTEROL INCREASED 11 0.0002
944 CONVULSION 13 0.0002
945 EMOTIONAL DISTRESS 27 0.0002
946 ASTHMA 25 0.0002
947 DISEASE PROGRESSION 26 0.0002
948 DEPENDENCE 12 0.0002
949 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
950 INJECTION SITE MASS 8 0.0002
951 PLATELET COUNT DECREASED 23 0.0002
952 BLOOD GLUCOSE INCREASED 40 0.0002
953 ECZEMA 11 0.0002
954 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
955 THROMBOCYTOPENIA 23 0.0002
956 ASCITES 6 0.0002
957 WHEEZING 12 0.0002
958 SWELLING FACE 13 0.0002
959 BLINDNESS 8 0.0002
960 SKIN EXFOLIATION 16 0.0002
961 DYSPNOEA EXERTIONAL 7 0.0002
962 DEVICE EXPULSION 12 0.0002
963 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
964 LEUKOPENIA 9 0.0002
965 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
966 NEUTROPHIL COUNT DECREASED 7 0.0002
967 INFLUENZA LIKE ILLNESS 14 0.0002
968 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
969 ANAPHYLACTIC REACTION 9 0.0002
970 PRODUCT SUBSTITUTION ISSUE 9 0.0002
971 PANCREATITIS 8 0.0002
972 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
973 DRUG DEPENDENCE 23 0.0001
974 RHEUMATOID ARTHRITIS 16 0.0001
975 OROPHARYNGEAL PAIN 13 0.0001
976 INJECTION SITE BRUISING 11 0.0001
977 FLUSHING 14 0.0001
978 SINUSITIS 14 0.0001
979 EPISTAXIS 10 0.0001
980 INJECTION SITE HAEMORRHAGE 10 0.0001
981 DRY SKIN 16 0.0001
982 NEUTROPENIA 16 0.0001
983 INJECTION SITE REACTION 8 0.0001
984 STOMATITIS 7 0.0001
985 INFUSION RELATED REACTION 7 0.0001
986 INJECTION SITE PRURITUS 7 0.0001
987 ALOPECIA 20 0.0001
988 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
989 BREAST CANCER 9 0.0001
990 ACNE 7 0.0001
991 TOXICITY TO VARIOUS AGENTS 14 0.0001
992 INJECTION SITE ERYTHEMA 9 0.0001
993 INJECTION SITE PAIN 16 0.0001